Business
Lunit Achieves Milestone at ECR 2025: 13 Oral Presentations Among 15 AI Studies, Demonstrating Unmatched Clinical Impact
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a landmark achievement at the European Congress of Radiology (ECR) 2025, taking place in Vienna, Austria, from February 26 to March 2. With 15 research abstracts accepted and 13 designated as oral presentations, this year's participation marks Lunit's largest and most influential presence at ECR to date.
About this update from Lunit Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a significant milestone in AI-powered radiology research","length":150,"tagName":"p"}]},{"val":[{"type":"text","content":"Key studies demonstrate AI's capability to replace one radiologist in double reading, detect subclinical breast cancer years in advance, and maintain robust performance despite image quality challenges","length":205,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":355,"olType":false},{"type":"text","content":"SEOUL, South Korea, Feb. 27, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a landmark achievement at the European Congress of Radiology (ECR) 2025, taking place in Vienna, Austria, from February 26 to March 2. With 15 research abstracts accepted and 13 designated as oral presentations, this year's participation marks Lunit's largest and most influential presence at ECR to date.","length":486,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/f0a526d8f08a741736401abd3ac73d71"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MrBmv6iZwoIK5zghaUagYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f0a526d8f08a741736401abd3ac73d71","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2629357/image_5011049_28823925.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The high acceptance rate underscores Lunit's growing leadership in AI-driven radiology, with its research recognized as highly relevant to the future of cancer screening and detection. Among the featured studies, two highlight groundbreaking findings that further solidify Lunit INSIGHT MMG as a clinically proven tool in mammography interpretation and workflow optimization.","length":379,"tagName":"p"},{"type":"text","content":"Replacing One Radiologist with AI for Independent Double Reading in Mammographic Screening","length":90,"tagName":"p"},{"type":"text","content":"Presented by Marie Burns Bergan from BreastScreen Norway, this study evaluates the i...